Succinate salt of 2-((4-(1-methyl-4-pyridin-4-yl)-1h-pyrazol-3-yl)phenoxy)methyl)quinoline

Abstract

The present invention relates to a succinate salt of 2-((4-(1-methyl-4-(pyridin-4-yl)-1H-pyrazol-3-yl)phenoxy)methyl)quinoline, and to a method for treating disorders of the Central Nervous System (CNS) and other disorders in a mammal, including a human, by administering to the mammal the succinate salt. It also relates to pharmaceutical compositions containing a pharmaceutically acceptable carrier and the succinate salt.

Dependencies are inferred from the claim text.